Search…

Zhongheng Group (600252.SH) controlled subsidiary has obtained the approval notification for drug supplement application.

12/05/2025

Zhijing Finance APP News, Zhongheng Group (600252.SH) announced that recently, its holding subsidiary Chongqing Lai Mei Pharmaceutical Co., Ltd. (hereinafter referred to as "Lai Mei Pharmaceutical") received the "Drug Supplementary Application Approval Notice" for two specifications of naloxone hydrochloride injection: 1ml:1mg and 2ml:2mg approved and issued by the National Medical Products Administration.

Latest

2 m ago

National Energy Administration: Will speed up research and introduction of non-fossil energy electricity consumption accounting methods.

3 m ago

The main stock index in Turkey rose by 4%, marking the largest increase since March 25th.

3 m ago

Hainan Provincial Meteorological Observatory continues to issue a yellow warning signal for thunderstorms and strong winds at sea at 22:40 on May 12, 2025: Thunderstorms and strong winds may occur in the southern waters of the island from 23:00 on the 12th to 08:00 on the 13th, with wind force reaching 7-9. accompanied by strong lightning, it is recommended that relevant units and personnel take precautions.

4 m ago

Chilean National Copper Corporation: An agreement has been reached with Rio Tinto Group to establish a joint committee and provide joint funding support for preliminary studies for an initial period of 12 months.

4 m ago

Chile's National Copper Corporation: Agreement with Rio Tinto Group to establish a joint committee and provide joint funding support for initial research for a period of 12 months.

See all latest